Sodium Bicarbonate Administration Post-ACLS
Sodium bicarbonate should NOT be routinely administered after ROSC following ACLS, as recent high-quality evidence shows no benefit for return of spontaneous circulation and no support for routine post-arrest use. 1
Evidence Against Routine Use
The most recent and highest quality evidence comes from a 2026 randomized, double-blind, placebo-controlled trial of 779 patients with in-hospital cardiac arrest 1. This study definitively showed:
- No significant difference in sustained ROSC between sodium bicarbonate and placebo (39% vs 37%, risk ratio 1.05)
- No improvement in 30-day survival (12% vs 9.1%)
- No improvement in favorable neurologic outcomes (8.1% vs 5.4%)
- Increased complications: more alkalosis and hypernatremia in the bicarbonate group
This contradicts older practice patterns where sodium bicarbonate was commonly used—one survey found it administered in 63.5% of cardiac arrests 2, and it remains a frequently used adjunct medication post-ROSC 3.
Current Guideline Recommendations
Neither the 2025 AHA Guidelines 4 nor the 2025 European Resuscitation Council Guidelines 5 recommend routine sodium bicarbonate administration post-ROSC. These guidelines focus on:
Immediate Post-ROSC Priorities (Not Including Bicarbonate):
- Airway management: Confirm advanced airway with waveform capnography 4, 5
- Oxygenation: Target SpO₂ 90-98% (PaO₂ 60-105 mmHg) 4 or 94-98% 5
- Ventilation: Target normocapnia (PCO₂ 35-45 mmHg) 4, 5
- Hemodynamics: Maintain MAP ≥65 mmHg with vasopressors (norepinephrine preferred) and fluids 4, 5
When Bicarbonate Might Be Considered (If At All)
If bicarbonate is used despite lack of evidence for routine administration, the FDA labeling provides dosing 6:
- Initial dose: 1-2 vials of 50 mL (44.6-100 mEq) given rapidly IV
- Subsequent doses: 50 mL (44.6-50 mEq) every 5-10 minutes
- Monitoring required: Arterial pH, blood gases, plasma osmolarity
- Caution: Hypertonic solutions may cause undesirable rise in plasma sodium
Important Caveats:
- The FDA label acknowledges that "in cardiac arrest, the risks from acidosis exceed those of hypernatremia" 6, but this predates the 2026 RCT showing no benefit
- Bicarbonate should be "planned in a stepwise fashion" with blood gas monitoring 6
- Avoid full correction in first 24 hours to prevent unrecognized alkalosis 6
Clinical Bottom Line
Do not routinely give sodium bicarbonate post-ROSC. Focus instead on the evidence-based post-cardiac arrest care bundle: airway management, oxygenation/ventilation targets, hemodynamic support with norepinephrine, temperature control (32-37.5°C for comatose patients), seizure evaluation with EEG, and early coronary angiography if indicated 4, 5, 7. The 2026 RCT provides definitive evidence against routine bicarbonate use, and current international guidelines do not recommend it.